BioMarin Pharmaceutical Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BMRN.MX | BIOCON.NS | BBIO | ALNY | ROIV | IONS | |
|---|---|---|---|---|---|---|
| Market cap | 213.90B | 571.90B | 12.98B | 31.02B | 24.22B | 7.14B |
| P/E (TTM) | 165.9 | 103.3 | — | 39.1 | — | — |
| Forward P/E | — | 31.9 | -260.0 | 18.6 | -19.5 | -38.6 |
| Price/book | 1.9 | 1.7 | -5.2 | 22.9 | 5.7 | 16.2 |
| Dividend yield | — | 0.14% | — | — | — | — |
| 1-year change | +11.39% | −1.17% | +18.02% | −52.81% | +89.01% | −41.62% |
| Today | 0.00% | −0.80% | −1.10% | −0.94% | −1.50% | −2.67% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All BMRN.MX news ›BioMarin Pharmaceutical Inc. $BMRN Stock: Assenagon Asset Management S.A. Lowers Position
Assenagon Asset Management S.A. trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities &…
BioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by UBS Group
Posted by Michael Walen on Oct 15th, 2026 Stock analysts at UBS Group initiated coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “buy” rating and a…
BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Expected to Rise, Barclays Analyst Says
Posted by Danessa Lincoln on Oct 14th, 2026 BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price upped by Barclays from $111.00 to $114.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage…
1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.'s Acquisition of Alesta Therapeutics
Oct 14, 2026, 08:00 ET ALE1 advanced by 1cBio prior to its worldwide licensing agreement with Alesta Therapeutics 1cBio retains future economic interest in the ALE1 program for hypophosphatasia under the Alesta license agreement assumed by…
Abivax Says Chris Rabbat to Succeed Fabio Cataldi as Chief Medical Officer
Abivax said Monday Fabio Cataldi will be leaving the company in the fourth quarter of 2026, and Chris Rabbat, who has led Global Medical Affairs since 2023, will succeed Cataldi as chief medical... Biotechnology & Medical Research Abivax…
Bank of America Securities Sticks to Its Buy Rating for BioMarin Pharmaceutical (BMRN)
Bank of America Securities analyst Jason Gerberry maintained a Buy rating on BioMarin Pharmaceutical today and set a price target of $86.00. Gerberry covers the Healthcare sector, focusing on stocks such as Merck & Company, Eli Lilly & Co,…
BioMarin Stock Slips As Pipeline Hype Fails To Impress
BioMarin Pharmaceutical ( (BMRN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement. For longer-term investors, BioMarin’s strong revenue growth, raised guidance, and healthy cash generation…
Biomarin Pharmaceutical Inc
Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets → BioMarin appears attractively valued at current levels. With a 13.7% upside to…
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Shares of biotech company BioMarin Pharmaceutical (NASDAQ: BMRN) jumped 3.3% in the afternoon session after the company agreed to acquire Alesta Therapeutics, a clinical-stage biotech company. According to a company press release, BioMarin…
Sweetgreen Announces Lauren Crowley as Chief People Officer
Sweetgreen (NYSE: SG) appointed Lauren Crowley as Chief People Officer, effective October 26, 2026, reporting directly to CEO Jonathan Neman. LOS ANGELES--(BUSINESS WIRE)-- Sweetgreen, Inc. (NYSE: SG), the mission-driven restaurant brand…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
themarketsdaily.com3
-
marketscreener.com2
-
247wallst.com1
-
biospace.com1
-
defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.